CRISPR Interference Efficiently Induces Specific and Reversible Gene Silencing in Human iPSCs

Apáti, 2013, Characterization of calcium signals in human embryonic stem cells and in their differentiated offspring by a stably integrated calcium indicator protein, Cell. Signal., 25, 752, 10.1016/j.cellsig.2012.12.024 Armanios, 2005, Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita, Proc. Natl. Acad. Sci. USA, 102, 15960, 10.1073/pnas.0508124102 Boettcher, 2015, Choosing the Right Tool for the Job: RNAi, TALEN, or CRISPR, Mol. Cell, 58, 575, 10.1016/j.molcel.2015.04.028 Bolouri, 2003, Transcriptional regulatory cascades in development: initial rates, not steady state, determine network kinetics, Proc. Natl. Acad. Sci. USA, 100, 9371, 10.1073/pnas.1533293100 Chen, 2013, Ultrasensitive fluorescent proteins for imaging neuronal activity, Nature, 499, 295, 10.1038/nature12354 Cong, 2013, Multiplex genome engineering using CRISPR/Cas systems, Science, 339, 819, 10.1126/science.1231143 Davidson, 2011, Current prospects for RNA interference-based therapies, Nat. Rev. Genet., 12, 329, 10.1038/nrg2968 Doench, 2014, Rational design of highly active sgRNAs for CRISPR-Cas9-mediated gene inactivation, Nat. Biotechnol., 32, 1262, 10.1038/nbt.3026 Doudna, 2014, Genome editing. The new frontier of genome engineering with CRISPR-Cas9, Science, 346, 1258096, 10.1126/science.1258096 Gaj, 2013, ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering, Trends Biotechnol., 31, 397, 10.1016/j.tibtech.2013.04.004 Gilbert, 2013, CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes, Cell, 154, 442, 10.1016/j.cell.2013.06.044 Gilbert, 2014, Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation, Cell, 159, 647, 10.1016/j.cell.2014.09.029 González, 2014, An iCRISPR platform for rapid, multiplexable, and inducible genome editing in human pluripotent stem cells, Cell Stem Cell, 15, 215, 10.1016/j.stem.2014.05.018 Haussecker, 2012, The business of RNAi therapeutics in 2012, Mol. Ther. Nucleic Acids, 1, e8, 10.1038/mtna.2011.9 Hayashi, 2015, Structure-based discovery of NANOG variant with enhanced properties to promote self-renewal and reprogramming of pluripotent stem cells, Proc. Natl. Acad. Sci. USA, 112, 4666, 10.1073/pnas.1502855112 Hockemeyer, 2011, Genetic engineering of human pluripotent cells using TALE nucleases, Nat. Biotechnol., 29, 731, 10.1038/nbt.1927 Huebsch, 2015, Automated video-based analysis of contractility and calcium flux in human-induced pluripotent stem cell-derived cardiomyocytes cultured over different spatial scales, Tissue Eng. Part C Methods, 21, 467, 10.1089/ten.tec.2014.0283 Jackson, 2003, Expression profiling reveals off-target gene regulation by RNAi, Nat. Biotechnol., 21, 635, 10.1038/nbt831 Kearns, 2014, Cas9 effector-mediated regulation of transcription and differentiation in human pluripotent stem cells, Development, 141, 219, 10.1242/dev.103341 Kim, 2014, A guide to genome engineering with programmable nucleases, Nat. Rev. Genet., 15, 321, 10.1038/nrg3686 Kim, 2013, TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions, Genome Biol., 14, R36, 10.1186/gb-2013-14-4-r36 Kim, 2013, A library of TAL effector nucleases spanning the human genome, Nat. Biotechnol., 31, 251, 10.1038/nbt.2517 Krueger, 2007, Insights into effective RNAi gained from large-scale siRNA validation screening, Oligonucleotides, 17, 237, 10.1089/oli.2006.0065 Lian, 2012, Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling, Proc. Natl. Acad. Sci. USA, 109, E1848, 10.1073/pnas.1200250109 Liao, 2013, The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote, Nucleic Acids Res., 41, e108, 10.1093/nar/gkt214 Lombardo, 2011, Site-specific integration and tailoring of cassette design for sustainable gene transfer, Nat. Methods, 8, 861, 10.1038/nmeth.1674 Ludwig, 2006, Feeder-independent culture of human embryonic stem cells, Nat. Methods, 3, 637, 10.1038/nmeth902 Mali, 2013, RNA-guided human genome engineering via Cas9, Science, 339, 823, 10.1126/science.1232033 Marston, 2012, How do MYBPC3 mutations cause hypertrophic cardiomyopathy?, J. Muscle Res. Cell Motil., 33, 75, 10.1007/s10974-011-9268-3 McFadden, 2005, The Hand1 and Hand2 transcription factors regulate expansion of the embryonic cardiac ventricles in a gene dosage-dependent manner, Development, 132, 189, 10.1242/dev.01562 Minami, 2014, Progranulin protects against amyloid β deposition and toxicity in Alzheimer’s disease mouse models, Nat. Med., 20, 1157, 10.1038/nm.3672 Miyaoka, 2014, Isolation of single-base genome-edited human iPS cells without antibiotic selection, Nat. Methods, 11, 291, 10.1038/nmeth.2840 Oyer, 2009, Aberrant epigenetic silencing is triggered by a transient reduction in gene expression, PLoS ONE, 4, e4832, 10.1371/journal.pone.0004832 Qi, 2013, Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression, Cell, 152, 1173, 10.1016/j.cell.2013.02.022 Schwartz, 2012, Long-QT syndrome: from genetics to management, Circ Arrhythm Electrophysiol, 5, 868, 10.1161/CIRCEP.111.962019 Shalem, 2014, Genome-scale CRISPR-Cas9 knockout screening in human cells, Science, 343, 84, 10.1126/science.1247005 Shi, 2015, Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains, Nat. Biotechnol., 33, 661, 10.1038/nbt.3235 Soriano, 1999, Generalized lacZ expression with the ROSA26 Cre reporter strain, Nat. Genet., 21, 70, 10.1038/5007 Spencer, 2014, Calcium transients closely reflect prolonged action potentials in iPSC models of inherited cardiac arrhythmia, Stem Cell Reports, 3, 269, 10.1016/j.stemcr.2014.06.003 Sterneckert, 2014, Investigating human disease using stem cell models, Nat. Rev. Genet., 15, 625, 10.1038/nrg3764 Sung, 2013, Knockout mice created by TALEN-mediated gene targeting, Nat. Biotechnol., 31, 23, 10.1038/nbt.2477 Takahashi, 2007, Induction of pluripotent stem cells from adult human fibroblasts by defined factors, Cell, 131, 861, 10.1016/j.cell.2007.11.019 Takeuchi, 2011, Chromatin remodelling complex dosage modulates transcription factor function in heart development, Nat. Commun., 2, 187, 10.1038/ncomms1187 Theodoris, 2015, Human disease modeling reveals integrated transcriptional and epigenetic mechanisms of NOTCH1 haploinsufficiency, Cell, 160, 1072, 10.1016/j.cell.2015.02.035 Tohyama, 2013, Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes, Cell Stem Cell, 12, 127, 10.1016/j.stem.2012.09.013 Wang, 2014, Genetic screens in human cells using the CRISPR/Cas9 system, Science, 343, 80, 10.1126/science.1246981 Wang, 2015, Identification and characterization of essential genes in the human genome, Science, 350, 1096, 10.1126/science.aac7041 Watanabe, 2007, A ROCK inhibitor permits survival of dissociated human embryonic stem cells, Nat. Biotechnol., 25, 681, 10.1038/nbt1310 Wiedenheft, 2012, RNA-guided genetic silencing systems in bacteria and archaea, Nature, 482, 331, 10.1038/nature10886